WHAT’S NEW LATEST ARTCILES

ActaStim® Latest Articles

Explore expert insights, clinical updates, and the latest research on bone growth stimulation. Stay informed on how ActaStim® supports recovery and advances spinal fusion outcomes.

Navigating the Path to Success in Medical Devices: Strategy, Reimbursement, and Competition

July 21, 2025
A patient using the ActaStim app to complete her daily system sync.

Theragen Launches New ActaStim Patient Insights Portal for Healthcare Professionals

September 23, 2024

TXI Partners with Redox to Help Healthcare Technology Companies Accelerate Improved Patient Care Outcomes

November 10, 2022

Theragen’s user friendly design garners a second patent for spine fusion bone growth stimulator

October 4, 2022

The best enterprise designs of 2022

September 15, 2022

Theragen Expands Treatment Access to Over 150 Million U.S. Residents

September 14, 2022

See all the ways ActaStim® can take you further

Learn how our bone growth stimulation system combines clinically proven therapy, continuous wearability and actionable, daily insights to support healing after spinal fusion surgery.
For patients
For providers

ActaStim® (spine fusion stimulator) or its use is covered by one or more of the following U.S. patents: 11,395,919; 11,426,574;11,717,685;11,759,637;11,857,785. Additional U.S. and foreign patents pending. 2471-WEB-003 Rev. B

10151 Deerwood Park Blvd
Building 400, Suite 100
Jacksonville, FL 32256

(800) 901-5667

linkedin.com/company/theragen

Neurotech NA Inc. is a wholly-owned
subsidiary of Theragen Inc.
11220 Assett Loop, Suite 210

Manassas, VA 20109

Privacy Policy | Terms of Use

© 2025 Theragen. All rights reserved.

New Page Coming Soon!